|
1
|
Rezende TM: deS ouza Freire M and Franco
OL: Head and neck cancer: Proteomic advances and biomarker
achievements. Cancer. 116:4914–4925. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Armstrong W, Vokes DE and Maisel RH:
Malignant tumors of the larynx, cummings otolaryngology head &
neck surgery (5th). America Mosby Elsevier. 482–511. 2010.
|
|
3
|
Jalali MM, Heidarzadeh A, Zavarei MJ and
Sarmast H: p53 overexpression impacts on the prognosis of laryngeal
squamous cell carcinomas. Asian Pac J Cancer Prev. 12:1731–1734.
2011.PubMed/NCBI
|
|
4
|
Nathan CO, Franklin S, Abreo FW and Nassar
R: DeB enedetti A and Glass J: Analysis of surgical margins with
the molecular marker eIF4E: A prognostic factor in patients with
head and neck cancer. J Clin Oncol. 17:2909–2914. 1999.PubMed/NCBI
|
|
5
|
Breda A, Konijeti R and Lam JS: Patterns
of recurrence and surveillance strategies for renal cell carcinoma
following surgical resection. Expert Rev Anticancer Ther.
7:847–862. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Van Houten VM, Leemans CR, Kummer JA,
Dijkstra J, Kuik DJ, van den Brekel MW, Snow GB and Brakenhoff RH:
Molecular diagnosis of surgical margins and local recurrence in
head and neck cancer patients, A prospective study. Clin Cancer
Res. 10:3614–3620. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nathan CO, Sanders K, Abreo FW, Nassar R
and Glass J: Correlation of p53 and the proto-oncogene eIF4E in
larynx cancers, Prognostic implications. Cancer Res. 60:3599–3604.
2000.PubMed/NCBI
|
|
8
|
Bradford CR, Kumar B, Bellile E, Lee J,
Taylor J, D'Silva N, Cordell K, Kleer C, Kupfer R, Kumar P, et al:
Biomarkers in advanced larynx cancer. Laryngoscope. 124:179–187.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gasco M and Crook T: The p53 network in
head and neck cancer. Oral Oncol. 39:222–231. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
De Benedetti A and Graff JR: eIF-4E
expression and its role in malignancies and metastases. Oncogene.
23:3189–3199. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cardesa A and Nadal A: Carcinoma of the
head and neck in the HPV era. Acta Dermatovenerol Alp Pannonica
Adriat. 20:161–173. 2011.PubMed/NCBI
|
|
12
|
Nathan CO, Liu L, Li B, Abreo FW, Nandy I
and De Benedetti A: Detection of the proto-oncogene eIF4E in
surgical margins may predict recurrence in head and neck cancer.
Oncogene. 15:579–584. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nathan CO, Amirghahri N, Rice C, Abreo FW,
Shi R and Stucker FJ: Molecular analysis of surgical margins in
head and neck squamous cell carcinoma patients. Laryngoscope.
112:2129–2140. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Salehi Z and Mashayekhi F: Expression of
the eukaryotic translation initiation factor 4E (eIF4E) and 4E-BP1
in esophageal cancer. Clin Biochem. 39:404–409. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Crew JP, Fuggle S, Bicknell R and Cranston
DW: deB enedetti A and Harris AL: Eukaryotic initiation factor-4E
in superficial and muscle invasive bladder cancer and its
correlation with vascular endothelial growth factor expression and
tumour progression. Br J Cancer. 82:161–166. 2000.PubMed/NCBI
|
|
16
|
Liangping X: The prognostic value of
pathological and molecular margins marked by p53 and elF4E in
laryngeal carcinoma. Chinese-German J Clin Oncol. 4:56–60.
2005.
|
|
17
|
Chakraborty S, Mohiyuddin SM, Gopinath KS
and Kumar A: Involvement of TSC genes and differential expression
of other members of the mTOR signaling pathway in oral squamous
cell carcinoma. BMC Cancer. 8:1632008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J,
Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin.
58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kokko LL, Hurme S, Maula SM, Alanen K,
Grénman R, Kinnunen I and Ventelä S: Significance of site-specific
prognosis of cancer stem cell marker CD44 in head and neck
squamous-cell carcinoma. Oral Oncol. 47:510–516. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Clark C, Shah S, Herman-Ferdinandez L,
Ekshyyan O, Abreo F, Rong X, McLarty J, Lurie A, Milligan EJ and
Nathan CO: Teasing out the best molecular marker in the AKT/mTOR
pathway in head and neck squamous cell cancer patients.
Laryngoscope. 120:1159–1165. 2010.PubMed/NCBI
|
|
21
|
Partridge M, Costea DE and Huang X: The
changing face of p53 in head and neck cancer. Int J Oral Maxillofac
Surg. 36:1123–1138. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Argiris A, Karamouzis MV, Raben D and
Ferris RL: Head and neck cancer. Lancet. 371:1695–1709. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chao YK, Chuang WY, Yeh CJ, Chang YS, Wu
YC, Kuo SY, Hsieh MJ and Hsueh C: High phosphorylated 4E-binding
protein 1 expression after chemoradiotherapy is a predictor for
locoregional recurrence and worse survival in esophageal squamous
cell carcinoma patients. J Surg Oncol. 105:288–292. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Waitzberg AF, Nonogaki S, Nishimoto IN,
Kowalski LP, Miguel RE, Brentani RR and Brentani MM: Clinical
significance of c-myc and p53 expression in head and neck squamous
cell carcinomas. Cancer Detect Prev. 28:178–186. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Song HS, Do YR, Kang SH, Jeong KY and Kim
YS: Prognostic significance of immunohistochemical expression of
p53 gene product in operable breast cancer. Cancer Res Treat.
38:218–223. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li S and Wei Q: The expression and the
clinical significance of eukaryotic translation initiation factors
4E and p53 in squamous cell carcinoma. Chinese-German J Clin Oncol.
8:286–288. 2009. View Article : Google Scholar
|
|
27
|
Boyle JO, Hakim J, Koch W, van der Riet P,
Hruban RH, Roa RA, Correo R, Eby YJ, Ruppert JM and Sidransky D:
The incidence of p53 mutations increases with progression of head
and neck cancer. Cancer Res. 53:4477–4480. 1993.PubMed/NCBI
|
|
28
|
Pihan GA, Wallace J, Zhou Y and Doxsey SJ:
Centrosome abnormalities and chromosome instability occur together
in pre-invasive carcinomas. Cancer Res. 63:1398–1404.
2003.PubMed/NCBI
|
